Franklin Genomic Advancements ETF
HELX
BATS
| Weiss Ratings | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Valuation | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $41.68 | |||
| Company Info | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Franklin Templeton, Inc | |||
| Manager/Tenure (Years) | Matthew J. Moberg (6) | |||
| Website | http://www.franklintempleton.com | |||
| Phone Number | 650-312-2000 | |||
| Fund Information | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Franklin Genomic Advancements ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Growth | |||
| Inception Date | Feb 25, 2020 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.32% | |||
| Dividend | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.10% | |||
| Asset Allocation | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.06% | |||
| Stock | 99.94% | |||
| U.S. Stock | 95.71% | |||
| Non-U.S. Stock | 4.23% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.69% | |||
| 30-Day Total Return | -1.67% | |||
| 60-Day Total Return | 8.07% | |||
| 90-Day Total Return | 1.77% | |||
| Year to Date Total Return | 15.04% | |||
| 1-Year Total Return | 29.39% | |||
| 2-Year Total Return | 32.87% | |||
| 3-Year Total Return | 51.29% | |||
| 5-Year Total Return | -18.15% | |||
| Price | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $43.79 | |||
| 1-Month Low Price | $40.99 | |||
| 1-Month High Price | $44.56 | |||
| 52-Week Low Price | $31.78 | |||
| 52-Week Low Price (Date) | Mar 24, 2026 | |||
| 52-Week High Price | $44.56 | |||
| 52-Week High Price (Date) | Sep 30, 2026 | |||
| NAV | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $40.98 | |||
| 1-Month High NAV | $44.49 | |||
| 52-Week Low NAV | $31.26 | |||
| 52-Week Low NAV (Date) | Mar 27, 2026 | |||
| 52-Week High NAV | $44.49 | |||
| 52-Week High Price (Date) | Sep 30, 2026 | |||
| Beta / Standard Deviation | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.94 | |||
| Standard Deviation | 21.91 | |||
| Balance Sheet | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 33.37M | |||
| Operating Ratios | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.50% | |||
| Turnover Ratio | 29.00% | |||
| Performance | HELX - BATS | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 27.46% | |||
| Last Bear Market Total Return | -13.27% | |||